ATC Group: D01AC01 Clotrimazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D01AC01 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D01 Antifungals for dermatological use
3 D01A Antifungals for topical use
4 D01AC Imidazole and triazole derivatives
5 D01AC01 Clotrimazole

Active ingredients in D01AC01

Active Ingredient Description
Clotrimazole

Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc.

Related product monographs

Title Information Source Document Type  
CANESTEN THRUSH INTERNAL CREAM 10% w/w Vaginal cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CLOMAZOL Vaginal cream Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
CLOTRIMADERM Vaginal cream Health Products and Food Branch (CA) MPI, CA: SPM
MYCORIL Vaginal tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Australia (AU)

Austria (AT)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Estonia (EE)

Finland (FI)

Ireland (IE)

Israel (IL)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.